1. Molnar N, and Dietmar W. Siemann. 2013. Angiopoietin-2 Axis Inhibitors: Current Status and Future Considerationsfor Cancer Therapy. CurrentAngiogenesis 2(1): 2-12.
2. Molnar N, and Dietmar W. Siemann. 2013. Combined Ang-2 and VEGF Targeting Therapiesin Renal Cell Carcinoma. Journalof Cancer Therapy 4(9B): 1-6.
3. Molnar N and Siemann DW. 2012. Inhibition ofendothelial/smooth muscle cell contact loss by the investigationalAngiopoietin-2 antibody MEDI3617. MicrovascularResearch 83(3):290-7.
4. Dai Y, Shi W, MolnarN, Siemann DW. 2012. Impact of tumor hypoxia. Src, and Met signaling in thedissemination of tumor cells. SignalingPathways and Molecular Mediators in Metastasis. Ed. Alessandro Fatatis.Springer.